Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area pi3k akt signaling akt'

Search results for: 'research area pi3k akt signaling akt'

Items 61-70 of 105

Page
per page
  1. NVP-BGT226
    A8488 NVP-BGT226
    Target: PI3K|mTOR
    Summary: PI3K/mTOR inhibitor,selective and novel
      insoluble in EtOH; insoluble in H2O; ≥16.28 mg/mL
  2. WAY-600
    B1641 WAY-600
    Target: mTOR
    Summary: MTOR inhibitor
      ≥12.38 mg/mL
  3. Endomorphin-1
    A1013 Endomorphin-1
    Summary: Agonist of μopioid receptors,highly potent and selective
      ≥14.9 mg/mL
  4. TG100713
    B2177 TG100713
    Target: PI3K
    Summary: pan-PI3K inhibitor
      soluble in DMSO
  5. GTP-Binding Protein Fragment, G alpha
    A1022 GTP-Binding Protein Fragment, G alpha
    Summary: Hydrolyzes GTP to GDP
      insoluble in EtOH; ≥162.3 mg/mL
  6. [Ser25] Protein Kinase C (19-31)
    A1033 [Ser25] Protein Kinase C (19-31)
    Summary: PKC substrate
      insoluble in EtOH; ≥155.9 mg/mL
  7. Plumbagin
    A4456 Plumbagin
    Summary: Anticancer agent
  8. GnRH Associated Peptide (GAP) (1-13), human
    A1020 GnRH Associated Peptide (GAP) (1-13), human
    Target: prolactin secretion|gonadotropin release
    Summary: Inhibitor of prolactin secretion
      insoluble in H2O; insoluble in EtOH; ≥74.6 mg/mL
  9. GSK1059615
    B2176 GSK1059615
    Target: PI3K|mTOR
    Summary: PI3K and mTOR inhibitor,potent and reversible
      insoluble in EtOH; insoluble in H2O; ≥8.33 mg/mL
  10. β-Pompilidotoxin
    A1132 β-Pompilidotoxin
    Target: sodium channels
    Summary: Slows Na+ channel inactivation
      ≥155.8 mg/mL

Items 61-70 of 105

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 103item
  2. Natural Products 1 item
  3. Protein 2item
  4. Peptides & Proteins 3item
Specificity
  1. Selective 56item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 3item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Akt 10item
  3. PI3K 21item
  4. Raf 6item
  5. Aurora Kinases 1 item
  6. mTOR 12item
  7. Androgen Receptors 1 item
  8. FLT3 1 item
  9. GSK-3 4item
  10. VEGFR 4item
  11. PDGFR 1 item
  12. Phosphodiesterases (PDEs) 1 item
  13. p38 4item
  14. PKB 1 item
  15. MEK 3item
  16. PORCN 1 item
  17. FGFR 1 item
  18. GABAB Receptors 1 item
  19. NMDA Receptors 1 item
  20. STAT 4item
  21. EGFR 2item
  22. JAK 3item
  23. DNA-PK 3item
  24. HSP90 1 item
  25. Toll-like receptors (TLRs) 1 item
  26. ERK 2item
  27. PKC 5item
  28. ALK 1 item
  29. PKG 1 item
  30. PKA 3item
  31. RSK 1 item
  32. Histamine H1 Receptors 1 item
  33. NO Donors / Precursors 1 item
  34. IL Receptors 1 item
  35. AChE 1 item
  36. BACE 1 item
  37. p70 rsk 1 item
  38. sodium channels 1 item
  39. Smoothened receptor 1 item
  40. Nrf2/ARE signal 1 item
  41. PPAR 1 item
  42. Antibiotic 1 item
  43. Prk 1 item
  44. ICAM 1 item
  45. Rho 1 item
  46. Thrombin Receptor 1 item
  47. prolactin secretion 1 item
  48. gonadotropin release 1 item
  49. TRPC channel 1 item
  50. PKD 1 item
  51. FKBP 1 item
  52. ATM 1 item
Related Disease
  1. Acute Myelogenous Leukemia 1 item
  2. Acute Myeloid Leukemia 2item
  3. Bladder Cancer 1 item
  4. Breast Cancer 15item
  5. Cancer 56item
  6. Cervical Cancer 1 item
  7. Colon Cancer 6item
  8. Colorectal Cancer 6item
  9. Glioblastoma 8item
  10. Glioma 4item
  11. Heart Failure 1 item
  12. Leukemia 6item
  13. Liver Cancer 1 item
  14. Lung Cancer 4item
  15. Lymphoma 2item
  16. Melanoma 5item
  17. Multiple Myeloma 1 item
  18. Myeloma 1 item
  19. Neuroblastoma 1 item
  20. Non-small Cell Lung Cancer 4item
  21. Ovarian Cancer 5item
  22. Pancreatic Cancer 6item
  23. Pancreatic Carcinoma 1 item
  24. Prostate Cancer 7item
  25. Pulmonary Fibrosis 1 item
  26. Renal Cancer 1 item
  27. Rheumatoid Arthritis 2item
  28. Thyroid Cancer 2item
  29. Type 2 Diabetes 1 item